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Objectives: We sought to assess the clinical and survival benefit of atrial fibrillation
surgery in patients submitted to mitral valve surgery after stabilization of postopera-
tive rhythm at 1 year.
Methods: One thousand seven hundred twenty-three patients were enrolled. Patients
with follow-up of longer than 1 year (n5 972) were divided into 3 groups according
to surface electrocardiographic rhythm during follow-up visits: stable sinus rhythm,
stable atrial fibrillation, and intermittent rhythms. Adverse cardiac event incidence
and predictors of long-term outcome were compared among the 3 groups.
Results: In-hospital mortality was 2.6%. Risk factors for mortality were the cut-and-
sew technique (odds ratio, 8.92; 95% confidence interval, 1.71–46.50; P5 .009) and
isolated left atrial procedure (odds ratio, 0.16; 95% confidence interval, 0.04–0.56;
P5 .004). At 1 year, 63.4% patients were in stable sinus rhythm. Stable sinus rhythm
was found to be associated with early and late survival (P 5 .01, log-rank analysis).
Multivariate binary logistic regression analysis found that left atrial dimension (odds
ratio, 0.97; 95% confidence interval, 0.96–0.99; P5 .005) and concomitant coronary
revascularization (odds ratio, 0.48; 95% confidence interval, 0.25–0.92; P 5 .027)
were independent predictors of stable sinus rhythm at 1 year after surgical interven-
tion. At 48 months’ follow-up, predictors for stable sinus rhythmwere biatrial surgical
approach and absence of preoperative permanent atrial fibrillation (odds ratio, 3.56;
95% confidence interval, 1.62–7.83; P , .002). Left atrial size (each millimeter)
has a borderline statistical significance (odds ratio, 0.97; 95% confidence interval,
0.93–1.00; P 5 .065). Thromboembolic events were found to be associated with
absence of stable sinus rhythm (P 5 .010, log-rank analysis).
Conclusions: The achievement of stable sinus rhythm is a predictor of better survival
and lower incidence of thromboembolic events. Predictors of stable sinus rhythm
were smaller dimensions of the left atrium, biatrial approach, absence of preoperative
permanent atrial fibrillation, and absence of concomitant coronary artery bypass
grafting.
R
ecent reports of outcomes after atrial fibrillation treatment with mitral valve
surgery have been limited by the lack of a clear definition of patient selection
criteria and of consistent data on long-term results.1
Heart rhythm instability after these procedures is frequent. Nomenclature for these
different rhythms is not uniform, and results are often described as ‘‘out of atrial fibril-
lation’’ or ‘‘regular rhythms,’’ which have led to some misleading conclusions.1,2
Long-term use of concomitant antiarrhythmic medication after surgical intervention
is seldom reported.
The International Registry for Atrial Fibrillation Surgery (RAFS) covers a large
cohort of patients submitted to atrial fibrillation surgery in different clinical contexts.
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RAFS 5 International Registry for Atrial Fibrillation
Surgery
sAF 5 stable atrial fibrillation
sSR 5 stable sinus rhythm
RAFS uses a common nomenclature for clinical variables
and a standardized reporting method for the surgical proce-
dure and clinical outcomes.
The aim of this study was to assess the clinical and sur-
vival benefit, if any, of sinus rhythm recovery in the subset
of patients submitted to mitral valve surgery included in the
RAFS. Safety, efficacy, and benefits of atrial fibrillation sur-
gery were evaluated on short- and long-term data. Late use of
antiarrhythmic therapy was also assessed.
A classification based on heart rhythm stability after mitral
valve surgery was used. The effect of recovery of stable sinus
rhythm (sSR) on patient survival and on major adverse car-
diac events was studied.
Materials and Methods
Of 2140 patients enrolled in the RAFS, 1723 were submitted to con-
comitant mitral surgery. Data from these patients were collected864 The Journal of Thoracic and Cardiovascular Surgery c Apretrospectively from clinical reports between December 2003 and
March 2006. Patients were submitted to surgical intervention in
10 hospitals located in Europe and America enrolled in the
RAFS. Criteria used for the definition and classification of atrial
fibrillation were those recommended by the European Society of
Cardiology, American Heart Association, and American College
of Cardiology.3
A total of 56 variables were included concerning demographic
and clinical data at discharge and during follow-up. Common ac-
cepted nomenclature for the reported variables can be viewed at
www.registryafsurgery.com, with the most significant ones being
described in Table 1.
A standard protocol for valve or coronary surgery was used. All
patients were operated on during cardiopulmonary bypass, accord-
ing to local recommendations. Surgical techniques used to treat
atrial fibrillation and left atrial appendage closure were at the physi-
cians’ discretion (Table 2). In 283 (16.4%) patients the left atrial
appendage was left open.
Independent prognostic factors for in-hospital mortality were de-
termined for the total group of patients. Follow-up outcomes are
based on data from patients who have a minimum of 1 year’s fol-
low-up (n 5 972). The average follow-up for these patients was
29.0 6 21.4 months (median, 23 months; interquartile range 26.4
months).
In each of the 972 patients, rhythm was determined at every fol-
low-up visit according to the institutional protocol. Three institu-
tions used 24-hour Holter monitoring in the first 6 months and
electrocardiography at each follow-up visit thereafter, 1 institution
used either method throughout the follow-up period according toTABLE 1. Data from all patients according to concomitant cardiac procedures
Groups All (n 5 1723) M (n 5 925) M,A (n 5 205) M,T (n 5 259) M,C (n 5 86) M,A,T (n 5 71) M,O (n 5 179)
Age (y)
Mean 63 62 66 64 69 63 66
SD 11 11 10 11 7 13 10
Sex
% Male 39.5 38.5 38.5 28.6 73.3 25.4 51.0
Type of AF (%)
Paroxysmal 11.8 12.5 15.9 7.4 14.5 12.9 11.7
Persistent 11.6 12.4 18.3 8.1 24.1 2.9 7.3
Permanent 76.6 75.1 65.9 84.5 61.4 84.3 81.0
AF duration (y)
Mean 6.6 6.7 7.6 7.1 4.6 5.3 6.1
SD 6 6 7 7 5 5 6
Cause (%)
Rheumatic 50
Degenerative 19
Ischemic 3
Other 28
Previous TE 13 13 13 9 6 10 11
Size of LA (mm)*
Mean 57 58 56 57 52 55 54
SD 22 28 8 11 8 9 9
Mode 50 50 60 50 50 53 50
M, Mitral; A, aortic; T, tricuspid; C, coronary; O, other; SD, standard deviation; AF, atrial fibrillation; TE, thromboembolic events. *Echocardiographic measure-
ments were made according to each institution's protocol.ril 2008
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recordings.
Patients were divided into 3 groups according to the rhythm
documented during the first year: sSR, stable atrial fibrillation
(sAF), and intermittent rhythms. sSR was defined as sinus rhythm
at all follow-up visits during the first year.
A similar criterion was adopted for sAF. All other rhythms were
described as intermittent rhythms. Atrial flutter rhythm was consid-
ered as sAF for analysis purposes.
Adverse cardiac event incidence and predictors of long-term
outcome were compared in the 3 groups.
Summary statistics were presented as frequencies and percent-
ages, means 6 standard deviation, medians, and interquartile
ranges. Missing data were not defaulted to negative, and denomina-
tors reflect only actual reported cases.
Associations of outcomes among nominal variables were com-
pared by using the c2 test with the Yates correction or the 2-sided
Fisher exact test, when appropriate. Bivariate comparisons of con-
tinuous variables were investigated with the Student t test.
Survival analyses with Kaplan–Meier methods were performed
to estimate survival and freedom from thromboembolic events.
Cox proportional hazards models were used to identify the predic-
tors of early and late mortality and the predictors of maintenance
in sSR.
Iterative logistic modeling was performed for sSR by using the
likelihood ratio test for model selection.
Results
In-hospital mortality for the 1723 patients was 2.6% (n5 45;
99% confidence interval [CI], 1.7%–3.9%) Independent
TABLE 2. AF procedures
N %
Instrument type
Ablation 1679 97
Knife 44 3
Type of ablation
Dry unipolar RF 655 38
Irrigated unipolar RF 365 21
Dry bipolar RF 108 6
Microwave 462 27
Argon cryoablation 65 4
Other 68 4
Atrial approaches
Maze III 269 16
Non-maze Biatrial 335 19
Left side only 1117 65
Right side only 2 0.1
Left-sided techniques
(excluding maze)
BIPV 1076 74
Linear connection PV 127 9
Division of LA 219 15
Others 30 2
RF, Radiofrequency; BIPV, bilateral isolation of pulmonary veins; PV,
pulmonary veins; LA, left atrium.The Journal of Thopredictors for in-hospital mortality were the use of the cut-
and-sew technique (odds ratio [OR], 8.92; 95% CI, 1.71–
46.50; P , .009) and an isolated left atrial procedure (OR,
0.16; 95% CI, 0.04–0.56; P 5 .004).
In-hospital morbidity occurred in 153 (9%) patients (99
%CI, 7%–11%). These patients experienced 217 complica-
tions (Table 3), an average of 1.4 complications per patient.
The mean hospital stay was 12.46 10 days. At discharge,
59% of patients (n 5 971) were in sinus rhythm, 34% (n 5
554) were in atrial fibrillation, 2.6% (n 5 42) were in atrial
flutter, and the remaining 4.4% had other rhythms (n 5 99;
ie, nodal, sick sinus, and atrial heart rhythms). Of the 52 pa-
tients who required pacemaker implantation before dis-
charge, 20 (1.4%; 95% CI, 0.9%–2.2%) were submitted to
left-sided approaches, and 32 (6%; 95% CI, 4.0%–8.0%)
were submitted to biatrial approaches (P , .001).
Patients with follow-up of less than 1 year were excluded
from midterm analysis. Survival and embolic event analysis
were performed in the remaining 972 patients.
Rhythm at 1 year was documented by means of electrocar-
diography in 869 patients by using Holter monitoring in 101
patients and by means of intracavitary recordings in 2 pa-
tients.
Biatrial approaches were used in 307 of 972 patients, and
follow-up data at 1, 2, 3, and 4 years were available in 244,
104, 94, and 59 subjects, respectively.
At 1 year, 66% of patients were in sinus rhythm, 2.72%
were in atrial flutter, 25% were in atrial fibrillation, and
6.3% had other rhythms (atrial, nodal, and pacing).
One hundred fourteen (6.6%) patients died during follow-
up, and 144 adverse cardiac events were found in 120
(14.5%) patients. Considering the patient subset with long-
term follow-up (.48 months, n 5 181), the attrition rate
for losing sSR was 3% per year.
sSR was found to be associated with higher early and late
survival (P5 .01, log-rank analysis) when compared with all
other heart rhythms (Figures 1 and 2).
The use of antiarrhythmic therapy was similar in both
groups in early and long-term follow-up (Table 4). At 4
years, 34% of patients with sSR versus 21% of patients
with sAF were taking antiarrhythmic medication.
TABLE 3. Hospital morbidity
Type N
Cardiac 139
Lung 1
GI 23
CVA/TIA 4
Renal 16
Infectious 8
Miscellaneous 9
GI, Gastrointestinal; CVA/TIA, cerebral vascular accident/transient ische-
mic attack.racic and Cardiovascular Surgery c Volume 135, Number 4 865
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5) found that at 1 year after surgical intervention, left atrial
dimension was an independent predictor for sSR at 1 year af-
ter surgical intervention (OR, 0.97 for each millimeter; 95%
CI, 0.96–0.99; P5 .005). Concomitant coronary revascular-
ization was found to be an independent negative predictor of
sSR (OR, 0.48; 95% CI, 0.25–0.92; P 5 .027).
In the subset of patients with more than 48 months’ fol-
low-up, multivariate analysis (see Table 5) identified the
biatrial surgical approach (OR, 5.87; 95% CI, 1.94–17.74;
P 5 .002) and the absence of permanent atrial fibrillation
(OR, 4.00; 95% CI, 1.06–14.29; P5 .041) as significant pre-
dictors for sSR at 4 years. Left atrial size had a borderline sta-
tistical significance when considered as a continuous variable
(OR, 0.97 for each millimeter; 95% CI, 0.93–1.00; P5 .065)
but reached statistical significance when dichotomized (OR,
0.39 for left atrium.55 mm; 95% CI, 0.19–0.84; P 5 .015;
the best cutoff value was determined by means of receiver
operating curve analysis).
Figure 1. Actuarial survival after the first year of follow-up for
stable sinus rhythm (sSR) versus other rhythms.
Figure 2. Actuarial survival after the first year of follow-up ac-
cording to stable sinus rhythm (sSR) versus stable atrial fibrilla-
tion (sAF) versus ''other.''866 The Journal of Thoracic and Cardiovascular Surgery c ApTwenty-five (3%) patients experienced thromboembolic
events. Thromboembolic events were found to be associated
with absence of sSR (P5 .010, log-rank analysis; Figure 3).
Discussion
Atrial fibrillation surgery in patients undergoing mitral valve
operations has become very common in the last decade. Al-
ternative techniques to the maze procedure were developed
over the years in an attempt to avoid its complexity while re-
taining effectiveness.4 Concomitantly, ablation techniques to
create atrial scars were used as an alternative to the classic
cut-and-sew technique.5-8 Despite these advances, the clini-
cal benefit of atrial fibrillation surgery and the best technique
to perform it remain unclear.
It is well known that sinus rhythm recovery is not always
achieved. Moreover, a significant number of patients can
TABLE 4. Antiarrhythmic therapy
sSR sAF
Year % 95% CI % 95% CI
1 34 30-38 30 26-34
2 30 25-37 24 17-32
3 41 31-49 31 21-43
4 34 24-47 21 11-35
5 54 38-69 20 10-36
sSR, Stable sinus rhythm; sAF, stable atrial fibrillation.
TABLE 5. Predictors for stable sinus rhythm at 1 and 4 years
Variable OR P value 95% CI
1 y
Age (each year) 0.98 .008 0.96-0.99
Female sex 1.05 .806 0.71-1.55
Permanent AF 0.68 .139 0.40-1.14
Knife vs ablation 1.10 .829 0.48-2.53
Biatrial approach 0.93 .722 0.64-1.37
Left atrial size (each mm) 0.97 .005 0.96-0.99
Concomitant surgery
Aortic 0.87 .646 0.48-1.57
Tricuspid 0.69 .083 0.45-1.05
Coronary 0.48 .027 0.25-0.92
4 y
Age (each year) 0.99 .541 0.95-1.03
Female sex 1.29 .578 0.52-3.20
Permanent AF 0.25 .041 0.07-0.94
Knife vs ablation 0.38 .059 0.14-1.04
Biatrial approach 5.87 .002 1.94-17.74
Left atrial size (each mm) 0.97 .065 0.93-1.00
Concomitant surgery
Aortic 0.52 .470 0.09-3.10
Tricuspid 0.64 .490 0.18-2.28
Coronary 0.36 .170 0.09-1.54
Results are from binary logistic regression analysis. OR, Odds ratio; CI, con-
fidence interval; AF, atrial fibrillation.ril 2008
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surgical intervention, probably as a result of the healing pro-
cess, neurohumoralmodulation, or both.9-12 Classifying these
patients based on their discharge rhythms makes them behave
as crossovers and creates confusion in outcome assessment.
The use of a clear definition of sSR in the first year after mi-
tral surgery enabled us to assess the clinical outcome of atrial
fibrillation surgery in those patients in whom it is truly effec-
tive (nearly two thirds in this registry) and identify sSRas apre-
dictor for survival anddecreased incidence of thromboembolic
events. This finding emphasizes the importance of identifying
those patients in whom the restoration of sinus rhythm is an
achievable goal andwho should be given the opportunity to at-
tain it. Our results suggest that appropriate patient selection
should take into account left atrial dimensions, concomitant
coronary heart disease, and the type of atrial fibrillation.
Concomitant myocardial revascularization was a negative
predictor of maintenance in sinus rhythm. This association
might reflect a more advanced stage of myocardial disease
and difficulties in controlling arrhythmia in the presence of
ischemia. These results are in contrast with the ones pub-
lished by Prasad and colleagues.13
As previously reported, left atrial dimension was an inde-
pendent predictor of sSR 1 year after surgical intervention.14
Our findings confirm that the likelihood of maintenance in si-
nus rhythm decreases as a continuum with increasing left
atrial size, with a best cutoff point at 55 mm. The presence
of preoperative permanent atrial fibrillation was a negative
independent predictor of sSR at 4 years but not at 1 year,
where it was surpassed by the short-term predictors left atrial
size and concomitant revascularization. According to our
findings, patients undergoing multiple valve procedures
should not be excluded as candidates for atrial fibrillation
treatment because concomitant non–mitral valve surgery
was not associated with a decrease in effectiveness. This
might reflect selection bias but also the fact that patients re-
quiring multiple valve procedures currently receive surgical
treatment at much earlier stages than a few years ago.
Figure 3. Survival free of thromboembolic events according to
rhythm. sSR, Stable sinus rhythm.The Journal of ThoInterestingly, a biatrial approach was an independent pre-
dictor for staying in sSR but was also associated with in-
creased in-hospital mortality and the need for a permanent
pacemaker. Further studies will be needed to identify the pa-
tients in whom the apparent benefit of this approach out-
weighs its potential risks. The greater effectiveness of
biatrial approaches is not surprising. The highest reported
rates of conversion to sinus rhythm belong to the maze pro-
cedure,9 a biatrial surgical technique. The importance of
right atrial intervention is also underscored by the modest
but instructive crude success rates (8%–12%) of previous
studies on catheter ablation with right atrial compartmental-
ization.10
The high prevalence of antiarrhythmic therapy postopera-
tively might also have contributed to the preservation of sinus
rhythm during follow-up. Although the use of antiarrhythmic
drugs might reflect an effort to keep these complex patients in
sinus rhythm, it is probablymagnified by the use ofb-blockers
and digoxin in the treatment of concomitant hypertension and
chronic heart failure.
Several limitations of this study must be acknowledged.
First, despite the large number of patients included in the reg-
istry, the sample size of this study is still suboptimal because
an important proportion of patients were lost to follow-up
during the first postoperative year and were excluded from
further analysis. Because the data were collected retrospec-
tively into a registry, patient selection and surgical technique
were largely unstandardized. The use of 12-lead electrocardi-
ography to establish rhythm during follow-up reflects the
rhythm at a given moment and overestimates the success
rate of these surgical procedures. Because treatment options
were not randomized, differences in outcome between a bia-
trial approach versus a left atrial approach only and cut-and-
sew methods versus ablation methods might reflect selection
bias rather than real differences in the safety and efficacy of
surgical techniques. Before establishing a definite relation-
ship between the achievement of sSR and improved out-
comes, the effect of variables, such as cardiovascular risk
factors that were not consistently recorded in this registry,
should be taken into account.
In spite of the above limitations, these are encouraging re-
sults that require confirmation in large randomized controlled
trials.
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Discussion
Dr Ralph J. Damiano (St Louis, Mo). I would like to congratulate
DrMelo for initiating this international registry and his coauthors for
participating in this noble endeavor. As time progresses, I have no
doubt it will yield very useful information and provide a broad
look at current surgical practice for the treatment of atrial fibrillation.
Already Dr Melo and his colleagues have assembled the largest re-
ported series of concomitant mitral and atrial fibrillation surgery.
Although the registry does represent a major contribution to the
field, it suffers from the shortcomings of all voluntary retrospective da-
tabases, and these shortcomings include selection and reporting bias
and significant inhomogeneity of the patient populations, surgical
skill, and technique anddiffering follow-up regimensbetween centers.
In my opinion the most significant finding of this study is that
sSR was associated with better early and late survival and fewer
thromboembolic events during the follow-up period. This has con-
firmed the work of Bando and others and adds further testimony
to the crucial importance of performing atrial fibrillation surgery
in patients who have chronic atrial fibrillation and are referred for
the treatment of valvular heart disease.
Dr Melo, I have a number of questions for you. First, was there
any attempt to standardize the follow-up between centers? For a868 The Journal of Thoracic and Cardiovascular Surgery c Appatient to be considered to be either in sSR or sAF, were electrocar-
diographic or Holter monitoring data required to document the
actual rhythm? If a patient had atrial flutter 6 months postoperatively
and required an interventional procedure to terminate the flutter but
then was in sinus rhythm at 1 year, would you consider that a failure
or a success?
Dr Melo. Of course, this is a retrospective database, and there-
fore there was not the possibility of standardizing follow-up, but
I should comment that if we have these activities to survive, we
have to be more scientific. Therefore we need further time in putting
together data prospectively instead of just to survive and to undoubt-
edly prove the things for which we are looking.
Regarding the information based on 12-lead electrocardiography
or surface electrocardiography, which, of course, has the drawbacks
of which we are all aware, at least there was an electrocardiogram to
support that information.
Regarding patients who need to be cardioverted within the first
semester and then remain in sinus rhythm, those patients would be
classified as in sSR.
Dr Damiano.How about if they required an interventional cath-
eterization to ablate atrial flutter, was that considered a success also
if they went into sSR?
Dr Melo. That patient would be censored for this study because
we have 2 or 3 patients. That patient represents a failure of surgical
intervention, and therefore he needs to go to the catheterization lab-
oratory for our goal of being very strict because, as you know, most
reports, including Dr Bando’s, are not talking about sinus rhythm.
He is talking about regular rhythms, and most reports are talking
about atrial fibrillation, which is a rather different issue.
Dr Damiano. My second question is that you had a wide range
of ablation technologies in your study. Did you notice that ablation
energy source had any effect on late results?
DrMelo. That is the $1 million question. We have to realize that
unipolar radiofrequency, as you know, is less and less used, as op-
posed to actual analysis from bipolar and argon cryoablation, which
are the energies that are currently being used. As you know, we had
4% and 5%. Therefore we did not make comparisons between dif-
ferent forms of ablation energy, but compared instead cut-and-sew
technique with ablation. We did not show any improved results us-
ing the cut-and-sew technique, even though we might have the
shortcoming of having only 44 patients with the cut-and-sew tech-
nique, which is at this point maybe more critical to understand
why most reports with the cut-and-sew techniques, which are
maze techniques, apparently have slightly better results.
Dr Damiano. In a study that we published in 2005 on predictors
of late recurrence after a full maze procedure, we found that the du-
ration of preoperative atrial fibrillation was the strongest predictor of
arrhythmia occurrence and operative failure. Did you find this to be
a predictor of sSR in your database?
DrMelo.No, and we looked thoroughly at that, and this is pretty
much coincident with several articles published individually by
several groups. It was not.
Dr Damiano. Finally, I was wondering whether you can explain
the relatively poor late results of patients in your registry? The 1-
year freedom from atrial fibrillation was only 66%, and if I have cal-
culated from your manuscript correctly, the drug-free sSR rate at 1
year was only 44%. This compares to certainly our own historical
rate, where we have sSRs of more than 95% at 10 years, and 75%ril 2008
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Melo et al Surgery for Acquired Cardiovascular Diseaseof those patients are drug free and in sinus rhythm, either a normal
sinus rhythm or a paced rhythm. Even with ablation devices, we are
presently getting more than 90% sSR at 1 year, and approximately
70% of patients are drug free. Do you believe that the worse results
in this registry are due to the fact that 65% of patients only under-
went left-sided procedures and you found that that was perhaps
a risk factor for worse results? Also, of the left-sided procedures,
three quarters of those patients only had pulmonary vein isolation,
which many investigators, including myself, would believe would
be an inadequate operation for patients with large left atria and
organic heart disease?
DrMelo. I think this is a very good question. I am not sure about
the answer, even though from your question you are implying the
answer. Number one, this is a pretty unselected patient population;
left atrial size is, on average, 57 mm. Therefore those are very sick
patients, at least a large number of patients, which might have af-
fected these results. On the other hand, I do concur with you and
it is currently my practice that we should be performing biatrial ap-
proaches now on the basis of these data, and those are on the basis of
our knowledge from the maze operation.
But more important than that, I think that you can dump, as you
promised, your data in our database to compare apples with apples,
which I am not sure we have been doing historically.
Dr Kevin D. Accola (Orlando, Fla). I congratulate the authors
for putting together such a nice registry because it certainly helps
clarify, with the array of energy sources, the results of this new tech-
nology. My question to you is about the cohort of patients who have
had a pacemaker; you listed that you did have some, but you really
did not elucidate that group of patients. Did this group of patients do
better going from a chronic atrial fibrillation state to a paced atrial
ventricular synchronous state? I would be interested in this because
we are still experiencing, in some studies and in our practice, a 12%
to 14% incidence of pacemaker insertion. Therefore I would be in-
terested if you looked at this cohort individually and if these patients
did better.
DrMelo.We did look at that, and we have an incidence of pace-
makers after left-sided approaches of 2%, and we have an incidence
of biatrial approaches, mazes plus whatever lines you do on the right
side, at 1 year of 10%. And those patients, if they had a sequential
pacemaker, they were considered in sSR, but if they had only
PVI, they would be atrial fibrillation patients. But I cannot give
you in detail what has happened to that particular group of patients
besides what I told you.The Journal of ThoDr Accola. As a follow-up, do you anticoagulate these patien
for a particular duration, or what is your guidance to us on that?
Dr Melo. I think there is no evidence at the moment from wha
ever source that it is safe to interrupt anticoagulation on these pa
tients, even if you close the left atrial appendage. Besides, yo
have very strongmedical evidence that it is dangerous to stop antico
agulants because in patients undergoing mitral surgery, who ar
mostly rheumatic, there is very good evidence. The oldest one
am aware of is coming from theMayoClinic showing that of thromb
in lone atrial fibrillation, more than 90% start in the left atrial append
age, but in the context of rheumatic fever, half of thrombi are in th
body of the left atriumbecause of the degenerative disease. Therefor
I think that in most patients, especially if they are rheumatic, I do no
believe it is safe to interrupt anticoagulants at this point.
Dr Guo-Wei He (Hong Kong, China). I congratulate you, D
Melo, on your excellent presentation. My question is actually ju
to touch on your response to the previous discussant. My questio
is related to rheumatic heart disease. As you know, I am from Chin
We have a big problem with rheumatic heart disease. Most patien
with mitral valve disease have a cause of rheumatic disease. There
fore I would like to know what is the incidence of rheumatic hea
disease in this group? Furthermore, and more importantly, are ther
any differences among those patients with rheumatic heart diseas
after mitral surgery and with atrial fibrillation surgery who remai
in sinus rhythm 1 year later compared with those who did no
have atrial fibrillation surgery regarding the rate of sinus rhythm
or 2 years later in patients who had mitral surgery with rheumati
heart disease, the other group of that cause?
Dr Melo. As to the cause of disease of these patients, as
showed, around 60% had rheumatic fever. As far as it concerns thes
patients, if you are dealing with patients with very enlarged atri
very diseased atria, sometimes they do not even have myocyte
and I think it is not worthwhile to perform atrial fibrillation, espe
cially because on those patients your success rate at 1 year, as w
have reported 10 years ago, is in the range of 15%. And now w
know by this kind of analysis that it is eventually worse for a patien
to be on an intermittent route than to be in atrial fibrillation. Th
worst scenario for those patients is the 4% or 5% of patients who
after these extensive procedures, instead of having a fibrillatin
atrium have a steady atrium, and I believe this is worse for thromb
We still are treating patients with rheumatic fever. In those patient
if they have a large left atrium, we do not perform the operation
I think it is not worthwhile.racic and Cardiovascular Surgery c Volume 135, Number 4 869
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